Jill Norris
Concepts (780)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Autoimmunity | 74 | 2023 | 835 | 9.670 |
Why?
| Diabetes Mellitus, Type 1 | 114 | 2023 | 3471 | 8.280 |
Why?
| Islets of Langerhans | 56 | 2023 | 745 | 7.770 |
Why?
| Autoantibodies | 90 | 2023 | 1382 | 7.070 |
Why?
| Arthritis, Rheumatoid | 47 | 2024 | 1001 | 6.980 |
Why?
| Diet | 27 | 2024 | 1178 | 4.240 |
Why?
| Vitamin D | 21 | 2022 | 362 | 4.170 |
Why?
| Rheumatoid Factor | 22 | 2024 | 156 | 3.860 |
Why?
| Fatty Acids, Omega-3 | 13 | 2020 | 125 | 3.800 |
Why?
| Celiac Disease | 20 | 2022 | 270 | 3.270 |
Why?
| Anti-Citrullinated Protein Antibodies | 11 | 2023 | 90 | 3.250 |
Why?
| Genetic Predisposition to Disease | 67 | 2023 | 2382 | 2.980 |
Why?
| Risk Factors | 103 | 2023 | 9549 | 2.500 |
Why?
| Polymorphism, Single Nucleotide | 59 | 2023 | 2135 | 2.450 |
Why?
| Glutens | 9 | 2021 | 56 | 2.340 |
Why?
| Lupus Erythematosus, Systemic | 8 | 2022 | 236 | 2.320 |
Why?
| Peptides, Cyclic | 21 | 2023 | 265 | 2.250 |
Why?
| Erythrocyte Membrane | 6 | 2015 | 52 | 2.230 |
Why?
| Child, Preschool | 97 | 2023 | 9938 | 2.120 |
Why?
| Infant | 98 | 2023 | 8625 | 2.070 |
Why?
| Breast Feeding | 21 | 2021 | 394 | 2.050 |
Why?
| Genome-Wide Association Study | 26 | 2023 | 1403 | 2.010 |
Why?
| Insulin Resistance | 43 | 2023 | 1214 | 1.970 |
Why?
| Female | 243 | 2023 | 64889 | 1.960 |
Why?
| Prospective Studies | 65 | 2023 | 6818 | 1.950 |
Why?
| Male | 229 | 2023 | 60792 | 1.920 |
Why?
| Humans | 322 | 2024 | 125131 | 1.760 |
Why?
| Child | 111 | 2023 | 20014 | 1.740 |
Why?
| DNA Methylation | 4 | 2021 | 516 | 1.740 |
Why?
| Family | 22 | 2023 | 640 | 1.730 |
Why?
| Diabetes Mellitus, Type 2 | 34 | 2023 | 2236 | 1.730 |
Why?
| Oxylipins | 3 | 2023 | 27 | 1.670 |
Why?
| Adiposity | 19 | 2017 | 529 | 1.670 |
Why?
| Disease Progression | 29 | 2022 | 2577 | 1.640 |
Why?
| Vitamin D Deficiency | 6 | 2018 | 167 | 1.570 |
Why?
| Infant Nutritional Physiological Phenomena | 8 | 2021 | 135 | 1.500 |
Why?
| Milk | 11 | 2018 | 133 | 1.500 |
Why?
| Infant Food | 9 | 2018 | 63 | 1.420 |
Why?
| Genotype | 50 | 2023 | 1960 | 1.380 |
Why?
| Cohort Studies | 53 | 2022 | 5348 | 1.260 |
Why?
| Follow-Up Studies | 41 | 2021 | 4824 | 1.260 |
Why?
| Insulin | 27 | 2021 | 2219 | 1.250 |
Why?
| Adiponectin | 11 | 2018 | 233 | 1.230 |
Why?
| Fatty Acids, Unsaturated | 3 | 2021 | 87 | 1.230 |
Why?
| Atherosclerosis | 18 | 2023 | 360 | 1.210 |
Why?
| Proportional Hazards Models | 19 | 2021 | 1191 | 1.190 |
Why?
| Middle Aged | 106 | 2021 | 29112 | 1.180 |
Why?
| HLA-DR Antigens | 15 | 2017 | 225 | 1.160 |
Why?
| Eating | 6 | 2023 | 388 | 1.150 |
Why?
| HLA-DR4 Antigen | 11 | 2021 | 76 | 1.140 |
Why?
| Body Mass Index | 32 | 2023 | 2174 | 1.140 |
Why?
| Case-Control Studies | 33 | 2023 | 3326 | 1.130 |
Why?
| Prenatal Exposure Delayed Effects | 8 | 2023 | 484 | 1.100 |
Why?
| Dietary Proteins | 6 | 2019 | 134 | 1.090 |
Why?
| Adult | 115 | 2021 | 33167 | 1.060 |
Why?
| Dietary Sucrose | 2 | 2020 | 55 | 1.050 |
Why?
| Biomarkers | 25 | 2024 | 3736 | 1.020 |
Why?
| Infant, Newborn | 48 | 2022 | 5456 | 0.970 |
Why?
| Seroconversion | 2 | 2021 | 47 | 0.920 |
Why?
| Obesity | 21 | 2021 | 2805 | 0.860 |
Why?
| Docosahexaenoic Acids | 5 | 2021 | 71 | 0.860 |
Why?
| Edible Grain | 5 | 2013 | 43 | 0.850 |
Why?
| Colorado | 36 | 2020 | 4471 | 0.850 |
Why?
| Metabolic Syndrome | 6 | 2021 | 399 | 0.830 |
Why?
| Longitudinal Studies | 19 | 2020 | 2669 | 0.820 |
Why?
| Incidence | 21 | 2023 | 2578 | 0.810 |
Why?
| Infant Formula | 5 | 2019 | 84 | 0.800 |
Why?
| Autoimmune Diseases | 8 | 2019 | 406 | 0.790 |
Why?
| Child Nutritional Physiological Phenomena | 4 | 2019 | 97 | 0.780 |
Why?
| HLA-DR3 Antigen | 9 | 2023 | 79 | 0.780 |
Why?
| Carnitine O-Palmitoyltransferase | 1 | 2021 | 47 | 0.770 |
Why?
| Epitopes | 5 | 2022 | 450 | 0.750 |
Why?
| Blood Glucose | 16 | 2018 | 2008 | 0.750 |
Why?
| Metabolomics | 5 | 2023 | 551 | 0.740 |
Why?
| Transglutaminases | 11 | 2021 | 145 | 0.740 |
Why?
| F2-Isoprostanes | 2 | 2015 | 17 | 0.730 |
Why?
| Environmental Exposure | 4 | 2020 | 424 | 0.730 |
Why?
| Mass Screening | 8 | 2021 | 1119 | 0.730 |
Why?
| Surveys and Questionnaires | 21 | 2022 | 5061 | 0.730 |
Why?
| Adolescent | 57 | 2023 | 19411 | 0.720 |
Why?
| Overweight | 6 | 2021 | 520 | 0.710 |
Why?
| HLA-DQ Antigens | 14 | 2018 | 179 | 0.710 |
Why?
| Fatty Acids, Omega-6 | 5 | 2020 | 47 | 0.710 |
Why?
| Mexican Americans | 5 | 2019 | 102 | 0.700 |
Why?
| Sugars | 1 | 2020 | 33 | 0.690 |
Why?
| Receptors, Calcitriol | 4 | 2016 | 58 | 0.690 |
Why?
| Inflammation Mediators | 4 | 2020 | 515 | 0.690 |
Why?
| Pregnancy | 26 | 2023 | 5922 | 0.680 |
Why?
| Phospholipids | 1 | 2021 | 210 | 0.670 |
Why?
| Age Factors | 25 | 2019 | 3152 | 0.660 |
Why?
| Immunoglobulin G | 8 | 2023 | 808 | 0.640 |
Why?
| Genetic Variation | 8 | 2017 | 970 | 0.640 |
Why?
| Phenotype | 27 | 2021 | 3153 | 0.630 |
Why?
| Genome, Human | 8 | 2017 | 396 | 0.620 |
Why?
| Immunoglobulin A | 9 | 2023 | 176 | 0.620 |
Why?
| Gene Frequency | 16 | 2021 | 528 | 0.620 |
Why?
| Milk Proteins | 3 | 2008 | 40 | 0.620 |
Why?
| Hypertension, Pregnancy-Induced | 1 | 2018 | 47 | 0.610 |
Why?
| Polymorphism, Genetic | 11 | 2021 | 669 | 0.600 |
Why?
| Aged | 47 | 2021 | 20859 | 0.600 |
Why?
| Maternal Nutritional Physiological Phenomena | 6 | 2021 | 158 | 0.590 |
Why?
| Family Health | 11 | 2017 | 209 | 0.590 |
Why?
| HLA Antigens | 14 | 2019 | 235 | 0.580 |
Why?
| Glutamate Decarboxylase | 12 | 2021 | 166 | 0.580 |
Why?
| Alleles | 13 | 2021 | 865 | 0.570 |
Why?
| Genetic Linkage | 11 | 2016 | 330 | 0.570 |
Why?
| Genetic Loci | 8 | 2020 | 299 | 0.550 |
Why?
| PPAR gamma | 3 | 2016 | 190 | 0.550 |
Why?
| Cytokines | 7 | 2020 | 1927 | 0.550 |
Why?
| Dietary Supplements | 7 | 2019 | 478 | 0.550 |
Why?
| Vitamin D3 24-Hydroxylase | 1 | 2016 | 15 | 0.540 |
Why?
| Arachidonic Acid | 2 | 2021 | 120 | 0.540 |
Why?
| Air Pollution | 2 | 2024 | 213 | 0.540 |
Why?
| Protein Tyrosine Phosphatase, Non-Receptor Type 22 | 8 | 2019 | 47 | 0.540 |
Why?
| Dietary Carbohydrates | 2 | 2015 | 161 | 0.530 |
Why?
| Sputum | 4 | 2021 | 293 | 0.520 |
Why?
| Diet Surveys | 7 | 2021 | 87 | 0.520 |
Why?
| Carbohydrates | 2 | 2015 | 63 | 0.520 |
Why?
| Homeostasis | 15 | 2023 | 605 | 0.520 |
Why?
| Diabetes, Gestational | 7 | 2020 | 289 | 0.520 |
Why?
| Feeding Methods | 1 | 2015 | 6 | 0.510 |
Why?
| Non-alcoholic Fatty Liver Disease | 6 | 2023 | 286 | 0.510 |
Why?
| Feeding Behavior | 4 | 2018 | 618 | 0.500 |
Why?
| Child Day Care Centers | 1 | 2015 | 34 | 0.490 |
Why?
| Population Surveillance | 4 | 2015 | 444 | 0.490 |
Why?
| Altitude | 1 | 2018 | 461 | 0.470 |
Why?
| Joints | 3 | 2013 | 87 | 0.470 |
Why?
| Micronutrients | 3 | 2017 | 82 | 0.460 |
Why?
| Chemokines | 2 | 2012 | 232 | 0.460 |
Why?
| Pedigree | 11 | 2020 | 506 | 0.460 |
Why?
| Glucose | 11 | 2023 | 995 | 0.460 |
Why?
| Intra-Abdominal Fat | 10 | 2021 | 102 | 0.460 |
Why?
| Dietary Fats, Unsaturated | 3 | 2011 | 23 | 0.460 |
Why?
| Tobacco Smoke Pollution | 3 | 2007 | 244 | 0.450 |
Why?
| Blood Pressure | 8 | 2020 | 1735 | 0.450 |
Why?
| Diet Records | 5 | 2019 | 81 | 0.450 |
Why?
| Energy Intake | 7 | 2023 | 463 | 0.440 |
Why?
| Fatty Acid Desaturases | 1 | 2013 | 34 | 0.440 |
Why?
| GTP-Binding Proteins | 5 | 2021 | 159 | 0.440 |
Why?
| Stress, Psychological | 2 | 2020 | 1044 | 0.440 |
Why?
| Dietary Fats | 3 | 2011 | 332 | 0.430 |
Why?
| Bacteroidaceae Infections | 1 | 2012 | 4 | 0.430 |
Why?
| Genetic Association Studies | 7 | 2020 | 391 | 0.420 |
Why?
| Pediatrics | 2 | 2020 | 1046 | 0.420 |
Why?
| Porphyromonas gingivalis | 1 | 2012 | 18 | 0.420 |
Why?
| Protein Tyrosine Phosphatase, Non-Receptor Type 2 | 1 | 2012 | 11 | 0.420 |
Why?
| Pregnancy in Diabetics | 3 | 2012 | 88 | 0.420 |
Why?
| Multivariate Analysis | 12 | 2021 | 1561 | 0.410 |
Why?
| C-Reactive Protein | 6 | 2018 | 381 | 0.410 |
Why?
| Cross-Sectional Studies | 12 | 2022 | 4854 | 0.410 |
Why?
| Periodontitis | 1 | 2012 | 55 | 0.410 |
Why?
| Ascorbic Acid | 3 | 2023 | 116 | 0.410 |
Why?
| Smoking | 9 | 2019 | 1635 | 0.400 |
Why?
| United States | 38 | 2022 | 13613 | 0.400 |
Why?
| Fluorocarbons | 2 | 2023 | 106 | 0.400 |
Why?
| Antibodies, Bacterial | 1 | 2012 | 130 | 0.400 |
Why?
| Risk Assessment | 12 | 2020 | 3274 | 0.390 |
Why?
| Exome | 4 | 2021 | 229 | 0.390 |
Why?
| Age of Onset | 9 | 2018 | 484 | 0.390 |
Why?
| Calcifediol | 1 | 2011 | 30 | 0.390 |
Why?
| Texas | 8 | 2014 | 202 | 0.380 |
Why?
| Genetic Testing | 7 | 2020 | 401 | 0.370 |
Why?
| RGS Proteins | 1 | 2011 | 12 | 0.370 |
Why?
| Extracellular Traps | 3 | 2021 | 40 | 0.370 |
Why?
| Waist-Hip Ratio | 3 | 2007 | 32 | 0.370 |
Why?
| Fetal Blood | 5 | 2021 | 278 | 0.370 |
Why?
| Europe | 12 | 2020 | 369 | 0.370 |
Why?
| Logistic Models | 10 | 2019 | 2040 | 0.370 |
Why?
| Quantitative Trait, Heritable | 2 | 2017 | 125 | 0.360 |
Why?
| Food, Fortified | 1 | 2010 | 37 | 0.360 |
Why?
| Quantitative Trait Loci | 8 | 2020 | 349 | 0.350 |
Why?
| Epigenesis, Genetic | 3 | 2021 | 557 | 0.350 |
Why?
| Membrane Proteins | 6 | 2019 | 1089 | 0.350 |
Why?
| Diabetes Mellitus | 6 | 2020 | 988 | 0.350 |
Why?
| Food Preferences | 1 | 2011 | 120 | 0.340 |
Why?
| Enzyme-Linked Immunosorbent Assay | 7 | 2019 | 837 | 0.340 |
Why?
| Exercise | 4 | 2021 | 1779 | 0.330 |
Why?
| Body Height | 2 | 2009 | 191 | 0.330 |
Why?
| Triglycerides | 5 | 2021 | 551 | 0.330 |
Why?
| Air Pollutants | 2 | 2024 | 324 | 0.320 |
Why?
| HLA-DQ beta-Chains | 7 | 2015 | 62 | 0.320 |
Why?
| Cholesterol, HDL | 4 | 2019 | 217 | 0.320 |
Why?
| Adipose Tissue | 7 | 2017 | 620 | 0.320 |
Why?
| Life Style | 5 | 2015 | 442 | 0.320 |
Why?
| Glycemic Index | 1 | 2008 | 24 | 0.310 |
Why?
| Oligonucleotide Array Sequence Analysis | 4 | 2021 | 785 | 0.310 |
Why?
| Prenatal Nutritional Physiological Phenomena | 3 | 2017 | 67 | 0.310 |
Why?
| Inflammation | 5 | 2022 | 2612 | 0.300 |
Why?
| Vaccines | 2 | 2023 | 380 | 0.300 |
Why?
| Calcitriol | 1 | 2008 | 55 | 0.300 |
Why?
| Vitamins | 3 | 2024 | 163 | 0.300 |
Why?
| Prognosis | 9 | 2021 | 3616 | 0.300 |
Why?
| Odds Ratio | 7 | 2019 | 1050 | 0.290 |
Why?
| Environmental Pollutants | 2 | 2024 | 124 | 0.290 |
Why?
| Probiotics | 2 | 2019 | 52 | 0.290 |
Why?
| Lipid Metabolism | 3 | 2019 | 485 | 0.280 |
Why?
| Psychology, Child | 1 | 2007 | 41 | 0.280 |
Why?
| Fetal Distress | 1 | 2006 | 13 | 0.280 |
Why?
| Lipase | 3 | 2019 | 81 | 0.280 |
Why?
| Bias | 3 | 2021 | 216 | 0.270 |
Why?
| Wheat Hypersensitivity | 1 | 2006 | 4 | 0.270 |
Why?
| Linkage Disequilibrium | 5 | 2011 | 288 | 0.270 |
Why?
| Contraceptives, Oral, Hormonal | 1 | 2006 | 23 | 0.270 |
Why?
| Heat-Shock Proteins | 1 | 2007 | 129 | 0.270 |
Why?
| Precision Medicine | 2 | 2020 | 378 | 0.270 |
Why?
| Young Adult | 21 | 2021 | 11384 | 0.270 |
Why?
| Abdominal Fat | 6 | 2017 | 48 | 0.270 |
Why?
| Immunoglobulin M | 5 | 2022 | 253 | 0.270 |
Why?
| Insulin Antibodies | 6 | 2016 | 104 | 0.270 |
Why?
| Pregnancy Complications, Cardiovascular | 1 | 2006 | 72 | 0.260 |
Why?
| Vitamin D-Binding Protein | 3 | 2021 | 15 | 0.260 |
Why?
| C-Peptide | 4 | 2017 | 142 | 0.260 |
Why?
| Nutritional Status | 2 | 2013 | 304 | 0.260 |
Why?
| Tumor Necrosis Factor-alpha | 3 | 2021 | 1198 | 0.250 |
Why?
| Protective Factors | 2 | 2016 | 95 | 0.250 |
Why?
| Genetic Markers | 6 | 2013 | 368 | 0.250 |
Why?
| Autoantigens | 5 | 2021 | 406 | 0.250 |
Why?
| Risk | 8 | 2019 | 896 | 0.250 |
Why?
| Insulin-Secreting Cells | 3 | 2018 | 334 | 0.250 |
Why?
| Sex Factors | 9 | 2019 | 1901 | 0.250 |
Why?
| Infant, Newborn, Diseases | 1 | 2006 | 110 | 0.240 |
Why?
| Rubella | 2 | 2023 | 22 | 0.240 |
Why?
| Cattle | 6 | 2017 | 1010 | 0.240 |
Why?
| CpG Islands | 2 | 2021 | 125 | 0.240 |
Why?
| Animals | 19 | 2022 | 34345 | 0.240 |
Why?
| Fatty Acids | 2 | 2021 | 414 | 0.240 |
Why?
| Chromosomes, Human, Pair 17 | 5 | 2008 | 63 | 0.240 |
Why?
| Time Factors | 15 | 2017 | 6780 | 0.230 |
Why?
| Glucose Tolerance Test | 10 | 2018 | 373 | 0.230 |
Why?
| Hypertension | 5 | 2020 | 1257 | 0.230 |
Why?
| Alanine Transaminase | 3 | 2021 | 153 | 0.230 |
Why?
| Fasting | 7 | 2015 | 269 | 0.230 |
Why?
| Body Composition | 5 | 2017 | 679 | 0.230 |
Why?
| Disease Susceptibility | 4 | 2020 | 343 | 0.230 |
Why?
| Bottle Feeding | 2 | 2018 | 22 | 0.220 |
Why?
| Intestinal Mucosa | 1 | 2008 | 543 | 0.220 |
Why?
| Lipids | 4 | 2019 | 629 | 0.220 |
Why?
| Mumps | 1 | 2023 | 24 | 0.220 |
Why?
| Erythrocytes | 2 | 2021 | 642 | 0.220 |
Why?
| Birth Weight | 3 | 2018 | 477 | 0.220 |
Why?
| Iron Overload | 1 | 2023 | 10 | 0.220 |
Why?
| Interleukin-6 | 2 | 2021 | 710 | 0.220 |
Why?
| Data Accuracy | 1 | 2024 | 66 | 0.220 |
Why?
| Arteriosclerosis | 6 | 2005 | 91 | 0.220 |
Why?
| Measles | 1 | 2023 | 40 | 0.220 |
Why?
| Seizures | 1 | 2006 | 381 | 0.220 |
Why?
| 25-Hydroxyvitamin D3 1-alpha-Hydroxylase | 2 | 2016 | 17 | 0.210 |
Why?
| Chromosome Mapping | 11 | 2009 | 527 | 0.210 |
Why?
| Protein-Arginine Deiminases | 3 | 2021 | 17 | 0.210 |
Why?
| Chickenpox | 1 | 2023 | 102 | 0.210 |
Why?
| Pediatric Obesity | 3 | 2018 | 540 | 0.210 |
Why?
| Seroepidemiologic Studies | 3 | 2012 | 154 | 0.200 |
Why?
| Receptor-Like Protein Tyrosine Phosphatases, Class 8 | 2 | 2021 | 58 | 0.200 |
Why?
| Nuclear Family | 3 | 2019 | 54 | 0.200 |
Why?
| Citrullination | 2 | 2020 | 12 | 0.200 |
Why?
| Urine | 1 | 2002 | 66 | 0.200 |
Why?
| Cotinine | 1 | 2002 | 80 | 0.190 |
Why?
| Citrulline | 2 | 2016 | 41 | 0.190 |
Why?
| Propensity Score | 1 | 2023 | 257 | 0.190 |
Why?
| Tandem Mass Spectrometry | 2 | 2021 | 431 | 0.190 |
Why?
| Aspartate Aminotransferases | 2 | 2019 | 97 | 0.190 |
Why?
| Sulfates | 1 | 2021 | 46 | 0.190 |
Why?
| Hydroxyeicosatetraenoic Acids | 1 | 2021 | 41 | 0.190 |
Why?
| Liver Glycogen | 1 | 2021 | 24 | 0.190 |
Why?
| Antibodies, Viral | 3 | 2019 | 561 | 0.190 |
Why?
| Lactones | 1 | 2021 | 58 | 0.190 |
Why?
| Apolipoproteins E | 1 | 2021 | 93 | 0.190 |
Why?
| Linoleic Acid | 1 | 2021 | 41 | 0.190 |
Why?
| Protein Phosphatase 1 | 1 | 2021 | 32 | 0.190 |
Why?
| Sunlight | 1 | 2001 | 69 | 0.190 |
Why?
| Arthralgia | 1 | 2021 | 51 | 0.190 |
Why?
| Transcription Factors | 2 | 2019 | 1604 | 0.180 |
Why?
| Specimen Handling | 1 | 2002 | 171 | 0.180 |
Why?
| Lod Score | 7 | 2017 | 76 | 0.180 |
Why?
| Glycogen Storage Disease | 1 | 2021 | 21 | 0.180 |
Why?
| Health Status | 2 | 2023 | 794 | 0.180 |
Why?
| Iodide Peroxidase | 1 | 2020 | 27 | 0.180 |
Why?
| Tumor Necrosis Factor Ligand Superfamily Member 15 | 1 | 2020 | 8 | 0.180 |
Why?
| Origin of Life | 1 | 2020 | 10 | 0.180 |
Why?
| Prediabetic State | 3 | 2012 | 241 | 0.180 |
Why?
| Isotopes | 1 | 2020 | 26 | 0.180 |
Why?
| Registries | 9 | 2019 | 2050 | 0.180 |
Why?
| Models, Genetic | 5 | 2017 | 607 | 0.180 |
Why?
| Fatty Liver | 3 | 2013 | 256 | 0.180 |
Why?
| Interleukin-8 | 1 | 2021 | 254 | 0.170 |
Why?
| Mental Recall | 4 | 2017 | 187 | 0.170 |
Why?
| Iron | 2 | 2023 | 236 | 0.170 |
Why?
| Peroxidase | 1 | 2020 | 184 | 0.170 |
Why?
| Reproducibility of Results | 8 | 2018 | 3047 | 0.170 |
Why?
| Gastroenteritis | 2 | 2019 | 66 | 0.170 |
Why?
| Toll-Like Receptors | 1 | 2020 | 170 | 0.170 |
Why?
| Self Report | 2 | 2022 | 750 | 0.170 |
Why?
| Parents | 2 | 2007 | 1309 | 0.170 |
Why?
| Survival Analysis | 4 | 2017 | 1341 | 0.170 |
Why?
| Linear Models | 3 | 2019 | 870 | 0.170 |
Why?
| Aged, 80 and over | 15 | 2019 | 6936 | 0.170 |
Why?
| Metabolic Clearance Rate | 3 | 2014 | 115 | 0.170 |
Why?
| Endocrinology | 1 | 2020 | 73 | 0.170 |
Why?
| Chromatography, High Pressure Liquid | 1 | 2021 | 502 | 0.170 |
Why?
| Antigens, Viral | 2 | 2019 | 182 | 0.160 |
Why?
| Transcription Factor 7-Like 2 Protein | 2 | 2017 | 24 | 0.160 |
Why?
| HLA-D Antigens | 2 | 2017 | 36 | 0.160 |
Why?
| Histones | 2 | 2021 | 561 | 0.160 |
Why?
| Health | 2 | 2013 | 80 | 0.160 |
Why?
| Interleukin-1beta | 1 | 2021 | 382 | 0.160 |
Why?
| Subcutaneous Fat | 5 | 2010 | 90 | 0.160 |
Why?
| Herpesvirus 4, Human | 1 | 2019 | 129 | 0.160 |
Why?
| Plasminogen Activator Inhibitor 1 | 2 | 2012 | 87 | 0.160 |
Why?
| Arthritis, Experimental | 1 | 2020 | 130 | 0.160 |
Why?
| Antibodies | 3 | 2011 | 396 | 0.150 |
Why?
| Gestational Age | 4 | 2020 | 797 | 0.150 |
Why?
| Interleukins | 1 | 2020 | 243 | 0.150 |
Why?
| Chromatography, Liquid | 1 | 2019 | 363 | 0.150 |
Why?
| Sensitivity and Specificity | 5 | 2015 | 1885 | 0.150 |
Why?
| Herpesviridae Infections | 1 | 2019 | 147 | 0.150 |
Why?
| Hypersensitivity | 1 | 2021 | 265 | 0.150 |
Why?
| Monocytes | 1 | 2020 | 523 | 0.150 |
Why?
| Consensus | 1 | 2020 | 577 | 0.150 |
Why?
| Enterovirus Infections | 3 | 2010 | 167 | 0.150 |
Why?
| Mucous Membrane | 1 | 2018 | 123 | 0.150 |
Why?
| Collagen | 1 | 2020 | 443 | 0.150 |
Why?
| Niacin | 1 | 2017 | 24 | 0.150 |
Why?
| Maternal Age | 3 | 2004 | 124 | 0.150 |
Why?
| Bone Density | 1 | 2021 | 459 | 0.140 |
Why?
| Sweden | 4 | 2018 | 65 | 0.140 |
Why?
| Socioeconomic Factors | 5 | 2017 | 1183 | 0.140 |
Why?
| Retrospective Studies | 13 | 2022 | 13708 | 0.140 |
Why?
| Oxidative Stress | 1 | 2003 | 1210 | 0.140 |
Why?
| Mothers | 4 | 2018 | 740 | 0.140 |
Why?
| Eicosapentaenoic Acid | 2 | 2013 | 29 | 0.140 |
Why?
| Germany | 4 | 2018 | 90 | 0.140 |
Why?
| Calcium | 1 | 2023 | 1211 | 0.140 |
Why?
| NFI Transcription Factors | 1 | 2016 | 5 | 0.140 |
Why?
| Neoplasm Proteins | 1 | 2020 | 409 | 0.140 |
Why?
| Respiratory Tract Infections | 2 | 2019 | 335 | 0.140 |
Why?
| Algorithms | 2 | 2023 | 1618 | 0.140 |
Why?
| Immunity, Innate | 1 | 2022 | 759 | 0.140 |
Why?
| Myocardial Infarction | 2 | 2021 | 1142 | 0.140 |
Why?
| Tomography, X-Ray Computed | 9 | 2017 | 2539 | 0.140 |
Why?
| Laminin | 1 | 2016 | 71 | 0.140 |
Why?
| Plasma Cells | 1 | 2016 | 60 | 0.130 |
Why?
| Regression Analysis | 7 | 2017 | 1047 | 0.130 |
Why?
| Complement System Proteins | 1 | 2019 | 295 | 0.130 |
Why?
| Adaptor Proteins, Signal Transducing | 3 | 2013 | 400 | 0.130 |
Why?
| Hydrolases | 2 | 2021 | 52 | 0.130 |
Why?
| Microsatellite Repeats | 2 | 2014 | 144 | 0.130 |
Why?
| Prenatal Care | 2 | 2017 | 277 | 0.130 |
Why?
| Niacinamide | 1 | 2016 | 71 | 0.130 |
Why?
| Adipogenesis | 1 | 2016 | 50 | 0.130 |
Why?
| Umbilical Cord | 1 | 2016 | 82 | 0.130 |
Why?
| Cardiovascular Diseases | 4 | 2021 | 1904 | 0.130 |
Why?
| Prevalence | 5 | 2017 | 2488 | 0.130 |
Why?
| Databases, Factual | 2 | 2018 | 1298 | 0.130 |
Why?
| Diet, High-Fat | 1 | 2017 | 251 | 0.130 |
Why?
| Isocitrate Dehydrogenase | 1 | 2015 | 38 | 0.130 |
Why?
| Haplotypes | 6 | 2008 | 496 | 0.130 |
Why?
| Arthritis | 1 | 2016 | 117 | 0.130 |
Why?
| Environment | 3 | 2019 | 355 | 0.130 |
Why?
| Predictive Value of Tests | 9 | 2018 | 1992 | 0.120 |
Why?
| Interleukin-2 | 2 | 2016 | 424 | 0.120 |
Why?
| Dietary Fiber | 1 | 2015 | 46 | 0.120 |
Why?
| Metabolome | 1 | 2018 | 307 | 0.120 |
Why?
| Early Diagnosis | 4 | 2019 | 237 | 0.120 |
Why?
| Mutation Rate | 1 | 2015 | 25 | 0.120 |
Why?
| Hydrocarbons, Chlorinated | 1 | 2014 | 23 | 0.120 |
Why?
| Mental Health | 1 | 2020 | 594 | 0.120 |
Why?
| Self Disclosure | 2 | 2007 | 65 | 0.120 |
Why?
| Minority Groups | 3 | 2011 | 251 | 0.120 |
Why?
| Vaccination | 1 | 2022 | 1241 | 0.120 |
Why?
| Gene-Environment Interaction | 4 | 2018 | 205 | 0.120 |
Why?
| Serum Albumin, Bovine | 1 | 1994 | 68 | 0.120 |
Why?
| Beverages | 1 | 2014 | 70 | 0.110 |
Why?
| Pesticides | 1 | 2014 | 67 | 0.110 |
Why?
| Selenoprotein P | 1 | 2013 | 3 | 0.110 |
Why?
| Intracellular Signaling Peptides and Proteins | 2 | 2023 | 410 | 0.110 |
Why?
| Leukocytes, Mononuclear | 1 | 2016 | 517 | 0.110 |
Why?
| Siblings | 3 | 2010 | 252 | 0.110 |
Why?
| Liver | 5 | 2023 | 1872 | 0.110 |
Why?
| Finland | 3 | 2018 | 72 | 0.110 |
Why?
| Immunoglobulins | 2 | 2015 | 155 | 0.110 |
Why?
| Asthma | 2 | 2023 | 2150 | 0.110 |
Why?
| Geographic Information Systems | 1 | 2013 | 42 | 0.110 |
Why?
| Severity of Illness Index | 3 | 2019 | 2848 | 0.110 |
Why?
| Interleukin-9 | 1 | 2012 | 11 | 0.100 |
Why?
| Genes, MHC Class II | 1 | 2012 | 73 | 0.100 |
Why?
| Chromosomes, Human, Pair 3 | 3 | 2010 | 52 | 0.100 |
Why?
| Tuberculosis, Bovine | 1 | 2012 | 3 | 0.100 |
Why?
| Quality of Life | 2 | 2020 | 2580 | 0.100 |
Why?
| Cell Membrane | 1 | 2016 | 732 | 0.100 |
Why?
| Practice Guidelines as Topic | 1 | 2020 | 1530 | 0.100 |
Why?
| Alcohol Drinking | 1 | 2018 | 710 | 0.100 |
Why?
| Epistasis, Genetic | 3 | 2020 | 73 | 0.100 |
Why?
| Patient Compliance | 2 | 2015 | 571 | 0.100 |
Why?
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2012 | 155 | 0.100 |
Why?
| Bronchial Diseases | 1 | 2011 | 35 | 0.100 |
Why?
| 25-Hydroxyvitamin D 2 | 1 | 2011 | 7 | 0.100 |
Why?
| HLA-DRB1 Chains | 3 | 2012 | 100 | 0.100 |
Why?
| Body Fat Distribution | 2 | 2013 | 48 | 0.100 |
Why?
| Child of Impaired Parents | 1 | 2012 | 46 | 0.100 |
Why?
| Fatty Acids, Nonesterified | 1 | 2012 | 174 | 0.100 |
Why?
| Vegetables | 2 | 2013 | 136 | 0.100 |
Why?
| Histocompatibility Testing | 3 | 2007 | 125 | 0.100 |
Why?
| Particulate Matter | 1 | 2013 | 252 | 0.090 |
Why?
| Environmental Monitoring | 1 | 2013 | 308 | 0.090 |
Why?
| Triticum | 1 | 2010 | 11 | 0.090 |
Why?
| Mice | 3 | 2022 | 15984 | 0.090 |
Why?
| Liver Cirrhosis | 2 | 2023 | 249 | 0.090 |
Why?
| Chi-Square Distribution | 1 | 2012 | 558 | 0.090 |
Why?
| Plant Proteins | 1 | 2011 | 83 | 0.090 |
Why?
| Peptide Fragments | 1 | 1994 | 713 | 0.090 |
Why?
| Statistics, Nonparametric | 2 | 2010 | 429 | 0.090 |
Why?
| Health Fairs | 1 | 2009 | 10 | 0.090 |
Why?
| DNA Primers | 3 | 2007 | 545 | 0.090 |
Why?
| Synovitis | 1 | 2009 | 24 | 0.090 |
Why?
| Gliadin | 1 | 2009 | 12 | 0.080 |
Why?
| Cholera Toxin | 1 | 2009 | 30 | 0.080 |
Why?
| Chromosomes, Human, Pair 1 | 3 | 2004 | 75 | 0.080 |
Why?
| Haptoglobins | 1 | 2009 | 30 | 0.080 |
Why?
| Fetal Weight | 1 | 2009 | 52 | 0.080 |
Why?
| Biopsy | 3 | 2015 | 1093 | 0.080 |
Why?
| I-kappa B Proteins | 1 | 2009 | 82 | 0.080 |
Why?
| Decision Support Techniques | 1 | 2013 | 395 | 0.080 |
Why?
| Receptors, Somatostatin | 1 | 2009 | 25 | 0.080 |
Why?
| Milk, Human | 1 | 2010 | 146 | 0.080 |
Why?
| Intestinal Absorption | 1 | 2009 | 104 | 0.080 |
Why?
| Suppressor of Cytokine Signaling Proteins | 1 | 2008 | 18 | 0.080 |
Why?
| Antigens, CD | 2 | 2009 | 466 | 0.080 |
Why?
| Interferon-gamma | 1 | 2012 | 749 | 0.080 |
Why?
| Rheumatology | 1 | 2010 | 90 | 0.080 |
Why?
| Nutrition Assessment | 3 | 2017 | 81 | 0.080 |
Why?
| Hypoglycemic Agents | 2 | 2015 | 1081 | 0.080 |
Why?
| Protein Precursors | 1 | 2009 | 125 | 0.080 |
Why?
| Seasons | 4 | 2019 | 474 | 0.080 |
Why?
| Immunization | 2 | 2022 | 420 | 0.080 |
Why?
| 3-Oxo-5-alpha-Steroid 4-Dehydrogenase | 1 | 2008 | 10 | 0.080 |
Why?
| Gastrointestinal Tract | 1 | 2010 | 175 | 0.080 |
Why?
| Antirheumatic Agents | 2 | 2015 | 258 | 0.080 |
Why?
| Permeability | 1 | 2008 | 155 | 0.080 |
Why?
| Alpha-Ketoglutarate-Dependent Dioxygenase FTO | 2 | 2023 | 24 | 0.080 |
Why?
| Artificial Intelligence | 1 | 2010 | 158 | 0.080 |
Why?
| Solanum tuberosum | 1 | 2008 | 9 | 0.080 |
Why?
| Organ Specificity | 2 | 2019 | 288 | 0.080 |
Why?
| Influenza Vaccines | 1 | 2012 | 504 | 0.070 |
Why?
| TCF Transcription Factors | 1 | 2007 | 21 | 0.070 |
Why?
| HLA-DP Antigens | 1 | 2007 | 33 | 0.070 |
Why?
| Seafood | 1 | 2007 | 17 | 0.070 |
Why?
| gamma-Glutamyltransferase | 2 | 2019 | 47 | 0.070 |
Why?
| Genotyping Techniques | 2 | 2017 | 78 | 0.070 |
Why?
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2007 | 44 | 0.070 |
Why?
| Diabetic Ketoacidosis | 1 | 2009 | 174 | 0.070 |
Why?
| Carotenoids | 1 | 2007 | 36 | 0.070 |
Why?
| Influenza, Human | 1 | 2012 | 569 | 0.070 |
Why?
| Fluorescent Antibody Technique | 2 | 2020 | 415 | 0.070 |
Why?
| Rotavirus | 1 | 2006 | 27 | 0.070 |
Why?
| Plethysmography | 2 | 2017 | 126 | 0.070 |
Why?
| Mutation | 1 | 2017 | 3520 | 0.070 |
Why?
| Cholesterol, LDL | 2 | 2019 | 341 | 0.070 |
Why?
| Delivery, Obstetric | 2 | 2004 | 131 | 0.070 |
Why?
| Glucose Intolerance | 2 | 2008 | 140 | 0.070 |
Why?
| Rotavirus Infections | 1 | 2006 | 55 | 0.070 |
Why?
| Weight Gain | 1 | 2009 | 517 | 0.070 |
Why?
| Societies, Medical | 2 | 2020 | 754 | 0.070 |
Why?
| Amino Acid Substitution | 1 | 2007 | 279 | 0.070 |
Why?
| Chromosomes, Human, Pair 11 | 1 | 2006 | 67 | 0.070 |
Why?
| Health Behavior | 1 | 2012 | 758 | 0.070 |
Why?
| Polymerase Chain Reaction | 4 | 2016 | 1042 | 0.060 |
Why?
| Pro-Opiomelanocortin | 1 | 2005 | 21 | 0.060 |
Why?
| Fibrinogen | 2 | 2019 | 164 | 0.060 |
Why?
| Trypsin Inhibitor, Kazal Pancreatic | 1 | 2005 | 4 | 0.060 |
Why?
| DNA | 2 | 2009 | 1406 | 0.060 |
Why?
| Gene Expression Regulation | 3 | 2016 | 2492 | 0.060 |
Why?
| Receptors, Adrenergic, beta-2 | 1 | 2005 | 44 | 0.060 |
Why?
| Genome Components | 1 | 2005 | 2 | 0.060 |
Why?
| Postpartum Period | 2 | 2021 | 289 | 0.060 |
Why?
| Lung Diseases | 1 | 2011 | 768 | 0.060 |
Why?
| Codon | 1 | 2005 | 90 | 0.060 |
Why?
| Arthritis, Juvenile | 1 | 2005 | 42 | 0.060 |
Why?
| Aging | 2 | 2009 | 1706 | 0.060 |
Why?
| Kaplan-Meier Estimate | 2 | 2017 | 879 | 0.060 |
Why?
| Amino Acid Sequence | 3 | 1999 | 2098 | 0.060 |
Why?
| Gastrointestinal Diseases | 2 | 2019 | 194 | 0.060 |
Why?
| Pulmonary Fibrosis | 1 | 2007 | 310 | 0.060 |
Why?
| Albuminuria | 1 | 2005 | 199 | 0.060 |
Why?
| Intestine, Small | 1 | 2005 | 135 | 0.060 |
Why?
| Likelihood Functions | 3 | 2012 | 141 | 0.060 |
Why?
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 3 | 2004 | 45 | 0.060 |
Why?
| Phospholipases | 1 | 2023 | 14 | 0.060 |
Why?
| Embryonic and Fetal Development | 1 | 2003 | 96 | 0.060 |
Why?
| Sleep | 1 | 2010 | 763 | 0.060 |
Why?
| Sequence Analysis, DNA | 2 | 2017 | 767 | 0.060 |
Why?
| Acyltransferases | 1 | 2023 | 54 | 0.060 |
Why?
| Radiography | 3 | 2013 | 893 | 0.050 |
Why?
| Intercellular Signaling Peptides and Proteins | 1 | 2005 | 371 | 0.050 |
Why?
| Iron, Dietary | 1 | 2023 | 19 | 0.050 |
Why?
| Transforming Growth Factor beta | 2 | 2022 | 457 | 0.050 |
Why?
| Protein Tyrosine Phosphatases | 3 | 2004 | 149 | 0.050 |
Why?
| Glutamates | 1 | 2023 | 64 | 0.050 |
Why?
| Proteins | 1 | 2009 | 951 | 0.050 |
Why?
| Abdomen | 1 | 2003 | 119 | 0.050 |
Why?
| Urban Health | 2 | 2006 | 88 | 0.050 |
Why?
| Income | 1 | 2003 | 183 | 0.050 |
Why?
| Nitrates | 1 | 1992 | 79 | 0.050 |
Why?
| Immunoglobulin Isotypes | 1 | 2022 | 31 | 0.050 |
Why?
| Nutrition Surveys | 2 | 2014 | 249 | 0.050 |
Why?
| Nerve Tissue Proteins | 2 | 2019 | 563 | 0.050 |
Why?
| Water Supply | 1 | 1992 | 74 | 0.050 |
Why?
| Epidemiologic Studies | 1 | 2021 | 64 | 0.050 |
Why?
| Selection Bias | 1 | 2021 | 35 | 0.050 |
Why?
| Pseudomonas Infections | 1 | 2003 | 192 | 0.050 |
Why?
| Immunization Schedule | 1 | 2022 | 188 | 0.050 |
Why?
| Diagnostic Techniques, Radioisotope | 1 | 2021 | 9 | 0.050 |
Why?
| Immunoglobulin D | 1 | 2021 | 28 | 0.050 |
Why?
| Prostatic Neoplasms | 1 | 2008 | 965 | 0.050 |
Why?
| Pregnancy Trimester, Third | 1 | 2021 | 82 | 0.050 |
Why?
| Serologic Tests | 1 | 2021 | 56 | 0.050 |
Why?
| Waist Circumference | 2 | 2013 | 130 | 0.050 |
Why?
| Electrochemical Techniques | 1 | 2021 | 42 | 0.050 |
Why?
| Financial Management | 1 | 2020 | 17 | 0.040 |
Why?
| Probability | 1 | 2021 | 318 | 0.040 |
Why?
| Asymptomatic Diseases | 1 | 2021 | 84 | 0.040 |
Why?
| Interleukin-10 | 1 | 2022 | 311 | 0.040 |
Why?
| Synovial Fluid | 1 | 2020 | 58 | 0.040 |
Why?
| Whole Genome Sequencing | 1 | 2020 | 117 | 0.040 |
Why?
| Glucose Transporter Type 2 | 1 | 2019 | 11 | 0.040 |
Why?
| Mannose | 1 | 2019 | 22 | 0.040 |
Why?
| Residence Characteristics | 2 | 2019 | 317 | 0.040 |
Why?
| Immunophenotyping | 1 | 2020 | 286 | 0.040 |
Why?
| Laryngitis | 1 | 2019 | 3 | 0.040 |
Why?
| Energy Metabolism | 2 | 2018 | 786 | 0.040 |
Why?
| Pregnancy Complications, Infectious | 1 | 2003 | 301 | 0.040 |
Why?
| Databases, Genetic | 1 | 2021 | 266 | 0.040 |
Why?
| Norway | 1 | 2019 | 37 | 0.040 |
Why?
| Sequence Homology | 1 | 1999 | 41 | 0.040 |
Why?
| Adenosine Diphosphate | 1 | 2019 | 90 | 0.040 |
Why?
| Conjunctivitis | 1 | 2019 | 19 | 0.040 |
Why?
| Body Weight | 2 | 2017 | 959 | 0.040 |
Why?
| Health Equity | 1 | 2020 | 65 | 0.040 |
Why?
| Health Plan Implementation | 1 | 2020 | 133 | 0.040 |
Why?
| Butyrates | 1 | 2019 | 55 | 0.040 |
Why?
| Maternal Behavior | 1 | 1999 | 69 | 0.040 |
Why?
| LIM-Homeodomain Proteins | 1 | 2019 | 15 | 0.040 |
Why?
| Immunoglobulin E | 1 | 2021 | 366 | 0.040 |
Why?
| Methotrexate | 1 | 2020 | 244 | 0.040 |
Why?
| Brazil | 1 | 2019 | 111 | 0.040 |
Why?
| Outpatients | 1 | 1992 | 347 | 0.040 |
Why?
| Powders | 1 | 2018 | 38 | 0.040 |
Why?
| Health Services | 1 | 1999 | 114 | 0.040 |
Why?
| Small-Area Analysis | 1 | 1997 | 10 | 0.040 |
Why?
| Fever | 1 | 2019 | 294 | 0.040 |
Why?
| Tobacco Products | 1 | 2019 | 122 | 0.040 |
Why?
| Hospitalization | 2 | 2004 | 1960 | 0.040 |
Why?
| Community Health Planning | 1 | 1997 | 42 | 0.040 |
Why?
| Multiple Trauma | 1 | 1998 | 103 | 0.040 |
Why?
| Diastole | 1 | 2018 | 146 | 0.040 |
Why?
| Whooping Cough | 1 | 1997 | 51 | 0.040 |
Why?
| Discriminant Analysis | 1 | 2017 | 42 | 0.040 |
Why?
| Microtubule-Associated Proteins | 1 | 2019 | 187 | 0.040 |
Why?
| Systole | 1 | 2018 | 190 | 0.040 |
Why?
| Multiple Organ Failure | 1 | 1998 | 167 | 0.040 |
Why?
| Health Planning | 1 | 1997 | 50 | 0.040 |
Why?
| Calcium-Binding Proteins | 1 | 2019 | 221 | 0.040 |
Why?
| Forecasting | 1 | 2019 | 379 | 0.040 |
Why?
| Pilot Projects | 1 | 2002 | 1530 | 0.040 |
Why?
| Muscle Proteins | 1 | 2019 | 224 | 0.040 |
Why?
| Otitis Media | 1 | 2019 | 154 | 0.040 |
Why?
| Blood Group Antigens | 1 | 1997 | 16 | 0.040 |
Why?
| Cholesterol | 1 | 2019 | 390 | 0.040 |
Why?
| Molecular Weight | 1 | 2017 | 345 | 0.040 |
Why?
| CTLA-4 Antigen | 2 | 2009 | 87 | 0.040 |
Why?
| DNA Mutational Analysis | 2 | 2010 | 394 | 0.040 |
Why?
| Genes, Immunoglobulin Light Chain | 1 | 2016 | 6 | 0.040 |
Why?
| Genes, Immunoglobulin Heavy Chain | 1 | 2016 | 10 | 0.040 |
Why?
| Phosphofructokinase-2 | 1 | 2016 | 14 | 0.030 |
Why?
| Insurance, Health | 1 | 1999 | 266 | 0.030 |
Why?
| Ataxia Telangiectasia Mutated Proteins | 1 | 2016 | 64 | 0.030 |
Why?
| Endpoint Determination | 1 | 2017 | 67 | 0.030 |
Why?
| Antibody Formation | 1 | 2018 | 282 | 0.030 |
Why?
| Acute Disease | 1 | 2019 | 1016 | 0.030 |
Why?
| Diabetes Complications | 1 | 2018 | 231 | 0.030 |
Why?
| Data Collection | 1 | 2019 | 682 | 0.030 |
Why?
| Complement Activation | 1 | 2019 | 350 | 0.030 |
Why?
| Th17 Cells | 1 | 2016 | 58 | 0.030 |
Why?
| Sirtuin 1 | 1 | 2016 | 31 | 0.030 |
Why?
| Los Angeles | 2 | 2008 | 62 | 0.030 |
Why?
| Enterovirus | 1 | 1997 | 73 | 0.030 |
Why?
| Models, Biological | 2 | 2019 | 1753 | 0.030 |
Why?
| Infant Mortality | 1 | 1996 | 95 | 0.030 |
Why?
| Protein Isoforms | 1 | 2017 | 354 | 0.030 |
Why?
| Mortality | 2 | 2007 | 327 | 0.030 |
Why?
| Evidence-Based Medicine | 1 | 2020 | 745 | 0.030 |
Why?
| DNA, Mitochondrial | 1 | 1997 | 191 | 0.030 |
Why?
| Disease-Free Survival | 1 | 2017 | 668 | 0.030 |
Why?
| Alzheimer Disease | 1 | 2021 | 529 | 0.030 |
Why?
| Georgia | 1 | 2015 | 61 | 0.030 |
Why?
| Florida | 1 | 2015 | 79 | 0.030 |
Why?
| Symptom Assessment | 1 | 2016 | 125 | 0.030 |
Why?
| Synovial Membrane | 1 | 2015 | 76 | 0.030 |
Why?
| Glucose-6-Phosphatase | 1 | 2015 | 32 | 0.030 |
Why?
| Patient-Centered Care | 1 | 2020 | 527 | 0.030 |
Why?
| Erythrocyte Count | 1 | 2014 | 20 | 0.030 |
Why?
| Australia | 1 | 1996 | 228 | 0.030 |
Why?
| Washington | 1 | 2015 | 138 | 0.030 |
Why?
| North America | 1 | 1996 | 271 | 0.030 |
Why?
| Databases, Nucleic Acid | 1 | 2014 | 37 | 0.030 |
Why?
| Solubility | 1 | 2015 | 241 | 0.030 |
Why?
| Blood Proteins | 1 | 1997 | 253 | 0.030 |
Why?
| Hematocrit | 1 | 2014 | 97 | 0.030 |
Why?
| Rituximab | 1 | 2015 | 159 | 0.030 |
Why?
| Cross-Cultural Comparison | 1 | 2015 | 85 | 0.030 |
Why?
| Glucagon-Like Peptide-1 Receptor | 1 | 2015 | 75 | 0.030 |
Why?
| Datasets as Topic | 1 | 2014 | 106 | 0.030 |
Why?
| Cholesterol Ester Transfer Proteins | 1 | 2014 | 19 | 0.030 |
Why?
| Isoenzymes | 2 | 2006 | 311 | 0.030 |
Why?
| Apolipoproteins | 1 | 2014 | 40 | 0.030 |
Why?
| Leukocyte Count | 1 | 2014 | 315 | 0.030 |
Why?
| Biomedical Research | 1 | 2020 | 641 | 0.030 |
Why?
| Antibodies, Antinuclear | 1 | 2014 | 58 | 0.030 |
Why?
| Lipoproteins, HDL | 1 | 2014 | 88 | 0.030 |
Why?
| Family Characteristics | 1 | 2015 | 171 | 0.030 |
Why?
| Birth Order | 2 | 2004 | 13 | 0.030 |
Why?
| Neurocan | 1 | 2013 | 1 | 0.030 |
Why?
| Chondroitin Sulfate Proteoglycans | 1 | 2013 | 9 | 0.030 |
Why?
| Treatment Outcome | 2 | 2004 | 9790 | 0.030 |
Why?
| Histocompatibility Antigens Class II | 2 | 2008 | 356 | 0.030 |
Why?
| Cystic Fibrosis | 1 | 2003 | 990 | 0.030 |
Why?
| Plant Roots | 1 | 2013 | 40 | 0.030 |
Why?
| Lysophospholipase | 1 | 2013 | 13 | 0.030 |
Why?
| Amino Acids, Branched-Chain | 1 | 2013 | 32 | 0.030 |
Why?
| Lectins, C-Type | 1 | 2013 | 67 | 0.030 |
Why?
| Glucose Clamp Technique | 1 | 2014 | 198 | 0.030 |
Why?
| Fetal Development | 1 | 2016 | 254 | 0.030 |
Why?
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 468 | 0.030 |
Why?
| Phosphoprotein Phosphatases | 1 | 2013 | 71 | 0.030 |
Why?
| Molecular Sequence Data | 2 | 1997 | 2926 | 0.030 |
Why?
| CD8-Positive T-Lymphocytes | 1 | 1998 | 717 | 0.030 |
Why?
| Hemoglobins | 1 | 2014 | 299 | 0.030 |
Why?
| HLA-DR2 Antigen | 1 | 2012 | 8 | 0.030 |
Why?
| Promoter Regions, Genetic | 2 | 2009 | 1195 | 0.030 |
Why?
| Public Health | 1 | 2017 | 493 | 0.030 |
Why?
| Culture | 1 | 2013 | 131 | 0.030 |
Why?
| Lung | 2 | 2017 | 3865 | 0.030 |
Why?
| Vaccines, Inactivated | 1 | 2012 | 69 | 0.030 |
Why?
| Antigens | 1 | 1994 | 324 | 0.030 |
Why?
| Fruit | 1 | 2013 | 133 | 0.030 |
Why?
| Ireland | 1 | 2012 | 29 | 0.030 |
Why?
| Dose-Response Relationship, Immunologic | 1 | 2012 | 83 | 0.030 |
Why?
| Intestines | 1 | 2015 | 337 | 0.030 |
Why?
| Tuberculin Test | 1 | 2012 | 34 | 0.030 |
Why?
| Feasibility Studies | 1 | 2015 | 806 | 0.030 |
Why?
| Genome | 1 | 2014 | 290 | 0.030 |
Why?
| Sentinel Surveillance | 1 | 2012 | 40 | 0.030 |
Why?
| Models, Statistical | 2 | 2009 | 664 | 0.030 |
Why?
| Arthrography | 1 | 2011 | 22 | 0.020 |
Why?
| Solvents | 1 | 2012 | 120 | 0.020 |
Why?
| Academic Medical Centers | 1 | 1994 | 447 | 0.020 |
Why?
| Practice Patterns, Physicians' | 1 | 2020 | 1280 | 0.020 |
Why?
| ROC Curve | 1 | 2013 | 501 | 0.020 |
Why?
| Silicon Dioxide | 1 | 2012 | 100 | 0.020 |
Why?
| Anxiety Disorders | 1 | 1994 | 333 | 0.020 |
Why?
| Indians, North American | 1 | 1997 | 600 | 0.020 |
Why?
| Leptin | 1 | 2012 | 233 | 0.020 |
Why?
| Dyslipidemias | 1 | 2013 | 169 | 0.020 |
Why?
| Child Abuse | 1 | 1996 | 538 | 0.020 |
Why?
| Women's Health | 1 | 2013 | 282 | 0.020 |
Why?
| Dose-Response Relationship, Drug | 1 | 2015 | 2026 | 0.020 |
Why?
| Blood Glucose Self-Monitoring | 1 | 2015 | 551 | 0.020 |
Why?
| Congresses as Topic | 1 | 2012 | 215 | 0.020 |
Why?
| Diabetic Angiopathies | 1 | 2012 | 276 | 0.020 |
Why?
| NF-KappaB Inhibitor alpha | 1 | 2009 | 52 | 0.020 |
Why?
| Obesity, Abdominal | 1 | 2010 | 41 | 0.020 |
Why?
| Space-Time Clustering | 1 | 1989 | 3 | 0.020 |
Why?
| Actuarial Analysis | 1 | 1989 | 24 | 0.020 |
Why?
| Sample Size | 1 | 2010 | 138 | 0.020 |
Why?
| Community-Institutional Relations | 1 | 2009 | 92 | 0.020 |
Why?
| Maternal Exposure | 1 | 2011 | 145 | 0.020 |
Why?
| Chromosomes, Human, Pair 2 | 1 | 2009 | 27 | 0.020 |
Why?
| Suppressor of Cytokine Signaling 3 Protein | 1 | 2008 | 8 | 0.020 |
Why?
| Ultraviolet Rays | 1 | 2012 | 417 | 0.020 |
Why?
| Southwestern United States | 1 | 2009 | 93 | 0.020 |
Why?
| Body Weights and Measures | 1 | 2008 | 37 | 0.020 |
Why?
| Disease | 1 | 2010 | 102 | 0.020 |
Why?
| Wounds and Injuries | 1 | 1996 | 833 | 0.020 |
Why?
| Genetic Carrier Screening | 1 | 2008 | 25 | 0.020 |
Why?
| Coxsackievirus Infections | 1 | 1987 | 12 | 0.020 |
Why?
| Health Surveys | 1 | 2010 | 481 | 0.020 |
Why?
| Sleep Deprivation | 1 | 2010 | 180 | 0.020 |
Why?
| Mice, Inbred C57BL | 1 | 2017 | 5102 | 0.020 |
Why?
| Survival | 1 | 2007 | 40 | 0.020 |
Why?
| Sex Distribution | 1 | 2008 | 384 | 0.020 |
Why?
| Reference Values | 2 | 1999 | 818 | 0.020 |
Why?
| Cause of Death | 1 | 1989 | 394 | 0.020 |
Why?
| Spleen | 1 | 2009 | 513 | 0.020 |
Why?
| RNA, Viral | 1 | 2010 | 587 | 0.020 |
Why?
| HLA-DP beta-Chains | 1 | 2007 | 79 | 0.020 |
Why?
| Recurrence | 1 | 2010 | 1011 | 0.020 |
Why?
| Chromosomes, Human, Pair 6 | 1 | 2006 | 49 | 0.020 |
Why?
| Base Sequence | 1 | 2010 | 2207 | 0.020 |
Why?
| Urban Population | 1 | 2009 | 433 | 0.020 |
Why?
| Receptors, Interleukin-4 | 1 | 2005 | 15 | 0.020 |
Why?
| Subcutaneous Fat, Abdominal | 1 | 2005 | 17 | 0.020 |
Why?
| Rural Health | 1 | 2006 | 78 | 0.020 |
Why?
| Antigens, Differentiation | 1 | 2005 | 79 | 0.020 |
Why?
| Rural Population | 1 | 2009 | 497 | 0.020 |
Why?
| Gene Expression | 1 | 2010 | 1528 | 0.020 |
Why?
| Albumins | 1 | 2005 | 106 | 0.020 |
Why?
| Interleukin-13 | 1 | 2005 | 134 | 0.020 |
Why?
| Open Reading Frames | 1 | 2005 | 125 | 0.020 |
Why?
| 3' Untranslated Regions | 1 | 2005 | 149 | 0.010 |
Why?
| Interleukin-4 | 1 | 2005 | 211 | 0.010 |
Why?
| Pancreatitis | 1 | 2005 | 111 | 0.010 |
Why?
| False Positive Reactions | 1 | 2004 | 122 | 0.010 |
Why?
| Primary Health Care | 1 | 1994 | 1660 | 0.010 |
Why?
| Motor Activity | 1 | 2009 | 689 | 0.010 |
Why?
| Chromosomes, Human, Pair 13 | 1 | 2003 | 18 | 0.010 |
Why?
| Chromosomes, Human, Pair 5 | 1 | 2003 | 27 | 0.010 |
Why?
| Growth | 1 | 2004 | 60 | 0.010 |
Why?
| Chromosomes, Human, Pair 19 | 1 | 2003 | 28 | 0.010 |
Why?
| Chromosomes, Human, Pair 16 | 1 | 2003 | 32 | 0.010 |
Why?
| Adult Children | 1 | 2003 | 22 | 0.010 |
Why?
| Chromosomes, Human, Pair 8 | 1 | 2003 | 35 | 0.010 |
Why?
| Radioimmunoassay | 1 | 2004 | 170 | 0.010 |
Why?
| Models, Theoretical | 1 | 2008 | 585 | 0.010 |
Why?
| Single-Blind Method | 1 | 2004 | 286 | 0.010 |
Why?
| Confidence Intervals | 1 | 2004 | 341 | 0.010 |
Why?
| Genetics, Population | 1 | 2004 | 208 | 0.010 |
Why?
| Creatinine | 1 | 2005 | 507 | 0.010 |
Why?
| Remission Induction | 1 | 2004 | 258 | 0.010 |
Why?
| Transforming Growth Factor beta1 | 1 | 2004 | 169 | 0.010 |
Why?
| Causality | 1 | 2003 | 117 | 0.010 |
Why?
| Monte Carlo Method | 1 | 2003 | 150 | 0.010 |
Why?
| HLA-A Antigens | 1 | 2002 | 50 | 0.010 |
Why?
| Survival Rate | 1 | 2006 | 1799 | 0.010 |
Why?
| Epidemiologic Methods | 1 | 1992 | 74 | 0.010 |
Why?
| Neonatal Screening | 1 | 2003 | 158 | 0.010 |
Why?
| Morbidity | 1 | 1992 | 310 | 0.010 |
Why?
| Histocompatibility Antigens Class I | 1 | 2002 | 176 | 0.010 |
Why?
| Pseudomonas aeruginosa | 1 | 2003 | 306 | 0.010 |
Why?
| Double-Blind Method | 1 | 2004 | 1725 | 0.010 |
Why?
| Disease Models, Animal | 1 | 2010 | 3823 | 0.010 |
Why?
| Haemophilus influenzae type b | 1 | 1999 | 10 | 0.010 |
Why?
| Diphtheria-Tetanus-Pertussis Vaccine | 1 | 1999 | 26 | 0.010 |
Why?
| Poliovirus Vaccine, Inactivated | 1 | 1999 | 22 | 0.010 |
Why?
| Haemophilus Vaccines | 1 | 1999 | 27 | 0.010 |
Why?
| Capitation Fee | 1 | 1999 | 13 | 0.010 |
Why?
| Hepatitis B Vaccines | 1 | 1999 | 48 | 0.010 |
Why?
| Genetic Counseling | 1 | 1999 | 69 | 0.010 |
Why?
| Chronic Disease | 1 | 2005 | 1684 | 0.010 |
Why?
| Randomized Controlled Trials as Topic | 1 | 2004 | 1324 | 0.010 |
Why?
| Office Visits | 1 | 1999 | 95 | 0.010 |
Why?
| Fee-for-Service Plans | 1 | 1999 | 95 | 0.010 |
Why?
| Platelet Count | 1 | 1998 | 89 | 0.010 |
Why?
| APACHE | 1 | 1998 | 65 | 0.010 |
Why?
| Medical Records | 1 | 1999 | 186 | 0.010 |
Why?
| Lymphocyte Count | 1 | 1998 | 140 | 0.010 |
Why?
| CD4 Lymphocyte Count | 1 | 1998 | 273 | 0.010 |
Why?
| Population Density | 1 | 1997 | 98 | 0.010 |
Why?
| Coronary Artery Disease | 1 | 2004 | 721 | 0.010 |
Why?
| Demography | 1 | 1998 | 295 | 0.010 |
Why?
| Fluid Therapy | 1 | 1998 | 155 | 0.010 |
Why?
| Polymorphism, Restriction Fragment Length | 1 | 1997 | 66 | 0.010 |
Why?
| Age Distribution | 1 | 1997 | 384 | 0.010 |
Why?
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 1998 | 311 | 0.010 |
Why?
| Marital Status | 1 | 1996 | 47 | 0.010 |
Why?
| Bacterial Infections | 1 | 1998 | 238 | 0.010 |
Why?
| Injury Severity Score | 1 | 1998 | 554 | 0.010 |
Why?
| Quality Control | 1 | 1996 | 165 | 0.010 |
Why?
| Virus Diseases | 1 | 1998 | 206 | 0.010 |
Why?
| T-Lymphocyte Subsets | 1 | 1998 | 406 | 0.010 |
Why?
| Marriage | 1 | 1997 | 116 | 0.010 |
Why?
| Blood Transfusion | 1 | 1998 | 312 | 0.010 |
Why?
| Medicaid | 1 | 1999 | 429 | 0.010 |
Why?
| Neoplasms | 1 | 1989 | 2340 | 0.010 |
Why?
| Viral Proteins | 1 | 1997 | 302 | 0.010 |
Why?
| Poverty | 1 | 1997 | 474 | 0.010 |
Why?
| Sex Characteristics | 1 | 1998 | 699 | 0.010 |
Why?
| Skinfold Thickness | 1 | 1992 | 50 | 0.010 |
Why?
| Psychiatric Status Rating Scales | 1 | 1994 | 537 | 0.010 |
Why?
| Emergency Medical Services | 1 | 1999 | 646 | 0.010 |
Why?
| Patient Discharge | 1 | 1997 | 857 | 0.010 |
Why?
| Psychometrics | 1 | 1994 | 691 | 0.010 |
Why?
|
|
Norris's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|